As of today, October 31, 2018 at 9:06pm EST, Presbia PLC (NASDAQ:LENS) has 17.16M shares outstanding with a float of 9.49M.
Presbia PLC’s yearly revenue of $16K provides them a gross profit of -$83K. Their current share price is $0.72. LENS is in the Healthcare sector and Medical Instruments & Supplies industry.
Profile:
Presbia is a medical device company focused on the development of the presbyopia-correcting Presbia Flexivue Microlens™ – an innovative solution for the common age-related loss of the ability to read or focus on near objects. The 3mm diameter lens is implanted in a corneal pocket created by a femtosecond laser. Learn more about the Microlens solution.
This solution responds to the market’s need for a surgical procedure that is safe, effective, quick and easy to learn and implement. The Presbia Flexivue Microlens™ solution relies on surgical equipment already in use at most eye surgery centers. Most distinguishing, the Presbia Flexivue Microlens™ is designed to be removable, meaning that the lens can be removed and replaced without any residual effect on the eye.
The Presbia Flexivue Microlens™ has received the CE mark for the European Economic Area, allowing the lens to be commercially available across Europe. The Presbia Flexivue Microlens™ has not been approved by the FDA and is not commercially available in the United States. Presbia is an ISO 13485 approved company.
Check out SOME latest tagged press releases:
-
-
- Presbia to Participate in the XXXVI Congress of the European Society of Cataract & Refractive Surgeons and in the German Ophthalmological Society Congress
- Reported by Business Wire on September 13, 2018
- Presbia Announces New Management Appointments
- Reported by Business Wire on February 13, 2018
- Presbia Announces Board and Management Changes and Financing Proposal to Operate Through to the End of 2018
- Reported by Business Wire on December 14, 2017
- Presbia to Participate in the XXXVI Congress of the European Society of Cataract & Refractive Surgeons and in the German Ophthalmological Society Congress
For more press releases see here.
SEC FILINGS
Location:
Sandyford Office Centre
Suite 7 17 Corrig Road Sandyford
Dublin 18
IrelandWebsite:
For more details on the company see here.
-